DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics

TipRanks

Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 50%

Is it time for the bears to break out the champagne glasses? Not so fast, says Goldman Sachs. Volatility has ruled the Street for the last few weeks, leading some to conclude that those with a more pessimistic outlook had been vindicated, but the firm believes stocks can still climb higher.According to Goldman Sachs’ head of U.S. equity strategy, David Kostin, the S&P 500 could still hit 3,600 by the end of the year, and 3,800 by mid-2021, on the back of vaccine-related optimism and progress with the economic reopening. This would reflect gains of 10% and 16%, respectively, should the index ultimately reach these targets.“Despite the sharp sell-off in the past week, we remain optimistic about the path of the U.S. equity market in coming months. The Superforecaster probability of a mass-distributed vaccine by Q1

Read More

Predictiv AI Inc. and Sigfox Canada Agree to Enter into Global Sales Channel and Technology Integration Partnership for ThermalPass

Sigfox is the world’s leading Internet of Things (IoT) service provider and first global 0G network operator. The agreement will see Predictiv AI and Sigfox Canada collaborate on integrating Sigfox connectivity into the ThermalPass. This will enable highly dependable data transfer through ThermalPass at a remarkably low cost on the Sigfox Canada network, which is designed to meet the requirements of mass IOT applications. This enhanced functionality will position ThermalPass to generate monthly recurring revenue by offering a multitude of enterprise scenarios.

In addition to the technology integration, Sigfox Canada will become a global non-exclusive sales distributor and will promote the ThermalPass offering to other Sigfox Operators in more than 70 countries. ThermalPass is a medical grade, sensor-based temperature scanning system developed to help mitigate the spread of COVID-19. The Sigfox global 0G network has more than 16,000,000 registered devices on the network communicating close to 1 billion messages per

Read More

New scheme to help 300 mid-career PMETs enter biomedical science sector over the next year

SINGAPORE: A new professional conversion programme (PCP) has been launched to help mid-career professionals, managers, executives and technicians (PMETs) join the biomedical science sector, which is still seeing growth despite the pandemic-induced economic downturn.

The 18-month PCP for Advanced Biopharmaceuticals Manufacturing Professionals and Executives is set to benefit 300 PMETs over the next year, said the Economic Development Board (EDB) and Workforce Singapore (WSG) in a joint press release on Wednesday (Aug 26).

The new scheme will replace the Attach-and-Train programme for biologics manufacturing – which was launched in November 2018 and has helped 185 people enter the sector so far – and go beyond biologics manufacturing to include specialisations in pharmaceuticals manufacturing, and cell and gene therapy.

READ: Why more Singaporeans are making a mid-career switch to a new job

READ: Healthcare sector to offer 7,500 jobs, 1,600 traineeships, attachments and skills training opportunities: MOH

The wider

Read More